SecBot SecBot
PRESS-RELEASE ·Filed May 15, 2026

TIL

Instil Bio
NEUTRAL
Impact 4/10
Horizonmonths Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

The company's strong cash position and reduced burn rate provide a long runway, but the lack of a disclosed pipeline or near-term catalyst means the stock will likely trade on any future acquisition or in-licensing announcements. Monitor for any definitive transaction agreements or strategic updates.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.07
T+0 close · May 15, 2026 · via day close
Latest settled
−7.19%
T+60 · $7.49
Vs SPY
−11.70%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $8.07entry
  2. T+1 · 6mo ago +0.74%α +0.81% · $8.13
  3. T+5 · 6mo ago +1.36%α +0.40% · $8.18
  4. T+20 · 5mo ago −1.86%α −3.98% · $7.92
  5. T+60 · 3mo ago −7.19%α −11.70% · $7.49
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Instil Bio reported Q1 2026 GAAP EPS of -$0.62, in line with the consensus estimate of -$0.59 (within the ±2% threshold). The company has $74.7M in cash, expected to fund operations beyond 2027, and is actively evaluating acquisition and in-licensing opportunities, though no specific transactions have been announced.

Key Financial Metrics

EPS
−$0.62
est −$0.59 · -5.1%
Revenue
$0.00
est $0.00
Rating
miss

Key Facts

  • GAAP net loss per share of $0.62 for Q1 2026, compared to $4.32 in Q1 2025
  • Non-GAAP net loss per share of $0.32 for Q1 2026, compared to $1.32 in Q1 2025
  • Cash, cash equivalents, restricted cash and marketable securities of $74.7M as of March 31, 2026
  • Cash runway expected to fund current operating plan beyond 2027
  • Company is actively evaluating acquisition and in-licensing opportunities
  • Research and development expenses decreased to $0.7M from $5.4M year-over-year
  • Restructuring and impairment charges of $1.0M, down from $16.1M year-over-year

Financial Impact

Net loss improved to $4.2M from $28.2M year-over-year; cash burn rate reduced significantly

net losscash positionoperating expenses

Risk Factors

  • No assurance that any acquisition or in-licensing transaction will materialize
  • Company currently has no disclosed pipeline or revenue-generating products
  • Forward-looking statements subject to risks including interest rates, inflation, and tariffs

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3295719

Track record

8 reports on TIL

Performance horizon
Filters
  1. Nov 16, 2026today 8-K Neutral 4/10 Entry $6.22 Now $5.75 −7.56% settles Dec 15
  2. Aug 13, 202613w ago Press Release Neutral 4/10 No price data
  3. Aug 13, 202613w ago 8-K Neutral 4/10 Entry $7.38 to $7.45 Now $5.75 −22.09% ▲ +0.95% +2.94% vs SPY
  4. May 15, 202626w ago 8-K Neutral 4/10 No price data
  5. May 15, 202626w ago Press Release Neutral 4/10 Viewing Entry $8.07 to $7.92 Now $5.75 −28.75% ▼ −1.86% −3.98% vs SPY
  6. Apr 24, 202629w ago DEFA14A Neutral 2/10 Entry $8.13 to $8.12 Now $5.75 −29.27% ▼ −0.12% −5.08% vs SPY
  7. Apr 3, 202632w ago 8-K Neutral 4/10 Entry $8.46 to $7.84 Now $5.75 −32.03% ▼ −7.33% −16.31% vs SPY
  8. Mar 27, 202633w ago Press Release Mixed 5/10 Entry $7.79 to $8.13 Now $5.75 −26.19% ▲ +4.36% −8.38% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026